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Among nutrients that can play a role in improving hu-
man health, two distinct classes of essential fatty acids, n-6 
and n-3, have received wide attention during the last de-
cades. The n-6 and n-3 fatty acids are fundamental nutrients 
that must be ingested as foods or dietary supplements.
Linoleic acid (LA) and -linolenic acid (ALA) are the 
parent fatty acids of the n-6 and n-3 groups, respectively. 
These 18-carbon fatty acids are required for the synthesis of 
longer PUFAs, such as arachidonic acid (AA), EPA, and 
DHA. Conversion of n-6 and n-3 fatty acids to PUFAs oc-
curs as a result of enzymatic desaturation and elongation 
steps. In addition, because the enzymes that are involved 
in these mechanisms have the same functions in the two 
fatty acid groups, the n-6 and n-3 fatty acids compete for 
them for their biosynthesis; in experimental animals, it 
has been shown that formation of n-3 long-chain PUFAs 
(LCPUFAs) is dependent on LA and total dietary PUFA 
concentration. However, the conversion rate of ALA to EPA, 
and particularly to DHA, is very low in humans (1). Thus, 
while both n-6 and n-3 fatty acids are essential for health, 
the balance of the two is critical, as well as the dietary intake 
of n-3 LCPUFAs, EPA, and DHA (2) (Scheme 1).
Over the last decades, the ratio of n-6 to n-3 fatty acid 
intake in the overall population, including children and 
adolescents, has dramatically shifted in the Western diet. In 
the eating habits of Western industrial countries, food 
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been associated with a number of neurological conditions. 
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In this context, endocannabinoids shape neuronal archi-
tecture (16), and recent preclinical studies comparing the 
effects of lifelong n-3-deficient to regular diets have pointed 
out that long-term ALA dietary insufficiency impairs endo-
cannabinoid-mediated long-term synaptic depression in 
brain areas associated with the development of anxiety- 
and depressive-like behaviors (17, 18), suggesting that life-
long deficiency in n-3 PUFAs may influence cerebral areas 
controlling mood through alteration of the endocannabi-
noid system functionality. However, the above-cited studies 
investigated the consequences of diets deficient in ALA 
and without comparing the effects of such dietary imbal-
ances to those present after administration of a healthy diet 
balanced in n-3 and n-6 fatty acid content.
The present study aimed at comparing the effects of life-
long administration of isocaloric diets enriched or defi-
cient in ALA, but containing similar amounts of LA, to 
those of a standard diet, with a balanced and recommended 
n-3/n-6 ratio. On this basis, we investigated whether: 1) im-
balanced amounts of ALA in the diet could be a sufficient 
condition for the development of altered emotional and 
cognitive behaviors at adulthood; and 2) these potential 
behavioral alterations could occur via dysregulations of the 
endocannabinoid system in selected brain regions regulat-
ing mood and cognition.
Diets were administered to healthy rats from pregnancy 
to adulthood and their consequences on measures of rec-
ognition and emotional memory, and depressive-, anxiety-, 
and psychotic-like behaviors were investigated in the adult 
male offspring. Subsequent biochemical analyses were car-
ried out in the prefrontal cortex (PFC), hippocampus, and 
amygdala to check for possible alterations in: 1) CB1 recep-
tor density and functionality; 2) protein expression of en-
docannabinoid synthetic and degradative enzymes; and 3) 
tissue levels of n-3- and n-6-derived endocannabinoids.
MATERIALS AND METHODS
Animals
Time-mated female Sprague-Dawley rats, starting from gesta-
tion day 1, were housed singularly in clear plastic cages on a 
12 h light-dark cycle (lights on 8:00 AM) and in a temperature- 
(22 ± 2°C) and humidity-controlled environment (50 ±10%) with 
a plastic tube for environmental enrichment. All animals had free 
access to food and water. Newborn litters found up to 5:00 PM 
were considered to be born on that day [postnatal day (PND) 0]. 
On PND 1, all litters were reduced to a standard size of eight pups 
per litter (four males and four females). At birth, litter weights, 
the total number of pups, and the number of males and females 
were measured. On PND 21, pups were weaned. All experiments 
took place on the male adult offspring during the light phase and 
were performed in accordance with the guidelines released by the 
Italian Ministry of Health (D.L. 2014/26) and the European Com-
munity directives regulating animal research (2010/63/EU). All 
efforts were made to minimize the number of animals used and 
their suffering.
Diet composition
Diets were provided by Dr. Piccioni Laboratories (Milan, Italy) 
and their composition was further assessed as follows.
tends to be rich in n-6 fatty acids and low in long-chain n-3 
fatty acids (3, 4). This dysregulation can affect the equilib-
rium of several organs and particularly of the brain that is 
highly enriched in LCPUFAs. Brain’s LCPUFAs are in-
volved in the maturation of neuronal structures and are 
essential throughout the entire lifespan for maintaining 
normal brain activities (5, 6). Consequently, it is unsurpris-
ing that a lack of n-3 LCPUFAs or an imbalance in the n-3 
and n-6 ratio has been associated with a number of neuro-
logical and psychiatric disorders, including depression, 
anxiety, schizophrenia, and attention deficit hyperactivity 
disorder in both children and adults (7–12).
Despite the growing body of evidence suggesting a link 
between n-3 LCPUFA dysregulation and neuropsychiatric 
diseases, how dietary fatty acids can actually affect the brain 
and behavior is still poorly understood.
The endocannabinoid system appears to be an ideal candi-
date for mediating the effects of dietary fatty acids on mood 
and cognition. Indeed, endocannabinoids are local neuro-
modulators that are metabolic derivatives of the n-6 LCPUFA, 
AA, and their concentrations in the brain are sensitive to 
modifications of the fatty acid composition of the diet (13, 
14). Furthermore, the endocannabinoid system plays a role 
in the regulation of mood and cognition under physiological 
conditions, and its dysregulation is believed to contribute to 
the development of several neuropsychiatric pathologies (15).
Scheme 1. Schematic representation of n-6 and n-3 metabolism.
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In the spatial variant of the test, the familiar object was placed in a 
different position compared with the familiarization phase; that is, 
a spatial cue was added in the test. During the test phase the time 
spent exploring the familiar object (Ef) and the time spent explor-
ing the new object (En) was videotaped and recorded separately by 
two observers blind to the treatment groups and the discrimina-
tion index was calculated as follows: [(En  Ef)/(En + Ef)] × 100.
Social interaction test. The test was carried out as previously re-
ported (22). During the test, each animal was allowed to freely 
explore an unfamiliar congener in an open-field box made of 
Plexiglas (60 × 60 × 60 cm) for 10 min and the total time spent in 
active social behaviors was recorded (as the sum of time spent in 
sniffing, following, grooming, mounting, and nosing during the 
test session) and the total number of aggressive episodes (attack-
ing, biting, tail rattling, and aggressive grooming).
Forced swim test. Animals were tested in a modified version of 
the forced swim test (FST) with only the first session of swimming 
as previously reported (22, 23) to measure a preexisting behav-
ioral deficit induced by diet administration.
Rats were forced to swim for 15 min inside a clear 50 cm tall, 
20 cm diameter glass cylinder filled to 30 cm with 25°C water. Dur-
ing the test, the following parameters were monitored: immobility 
(time spent by the animal floating in the water making only those 
movements necessary to keep its head above the water), swim-
ming (active swimming movements to the center of the cylinder), 
and climbing (forceful thrashing movements with forelimbs 
against the walls of the cylinder).
Elevated plus maze test. The test was performed as previously 
described (24). The elevated plus maze apparatus comprised two 
open arms (50 × 10 × 0 cm) and two closed arms (50 × 10 × 40 cm) 
that extended from a common central platform (10 × 10 cm). The 
apparatus, made of Plexiglas (gray floor, clear walls), was elevated 
to a height of 60 cm above the floor level. A video camera above 
the maze was connected to a television monitor connected to a 
videorecorder. Briefly, rats were individually placed on the cen-
tral platform facing a closed arm for 5 min. The following param-
eters were analyzed: percent of time spent on the open arms, 
number of open arm entries, and total arm entries.
Inhibitory avoidance. The inhibitory avoidance apparatus con-
sisted of a trough-shaped alley (91 cm long, 15 cm deep, 20 cm wide 
at the top, and 6.4 cm wide at the bottom) divided into two com-
partments separated by a sliding door. The starting compartment 
(31 cm long) was made of opaque white plastic and illuminated by 
a lamp; the shock compartment (60 cm long) was made of two dark 
electrifiable metal plates and was not illuminated. The procedure 
was carried out as previously described by Morena et al. (25). For 
training, rats were placed into the starting compartment facing 
away from the door and were allowed to explore the apparatus. Af-
ter the rats stepped completely into the dark compartment, the slid-
ing door was closed, and a single foot shock (0.4 mA) was delivered 
for 1 s. Animals were removed from the shock compartment 15 s 
after termination of the foot shock. Retention was tested 24 h later. 
On the retention test trial, rats were placed into the starting com-
partment, and the latency to re-enter the shock compartment with 
all four paws (maximum latency of 600 s) was recorded. Longer la-
tencies were interpreted as indicating better retention.
Prepulse inhibition of startle reflex. The test was carried out as pre-
viously descripted (26). Briefly, each rat was placed in a prepulse 
inhibition (PPI) apparatus (Med Associates, St. Albans, VT) for a 5 
min acclimatization period with a 70 dB background noise, which 
Lipid extraction
Food pellets were separately mixed with a mixture of CHCl3/
methanol (2:1 v/v) at a ratio of 1:10 (w/v). After homogenization, 
samples were filtered and transferred to a new test tube. The ex-
traction was done twice, and the two filtrates were combined to-
gether. A 0.9% NaCl solution was added to the recovered solution 
and centrifuged. The lower organic phase was removed, dried in 
vacuo, and stored at 80°C until analysis. Prior to analysis, dried 
lipid extracts were reconstituted in methanol.
GC-flame ionization detector analysis of fatty acid methyl 
esters
Lipids were derivatized to generate fatty acid methyl esters (FA-
MEs). The FAMEs were prepared as follows: 100 l of extracted 
lipids were saponified with 1 ml of sodium methylate in methanol 
(0.5% w/v) at 100°C for 15 min. After cooling, 1 ml of boron tri-
fluoride-methanol reagent was added and the solution was heated 
at 100°C for 15 min. The FAMEs were extracted by adding 1 ml of 
n-hexane, 4 ml of a saturated NaCl solution, and agitating manu-
ally for 2 min before a 5 min centrifugation (1,000 g). Finally, the 
n-hexane layer was transferred to a GC injector vial.
GC-flame ionization detector (FID) analyses were carried out 
on a GC2010 (Shimadzu, Milan, Italy) equipped with a split-split-
less injector (260°C) and a FID. FAME separation was performed 
on a Supelcowax column (Sigma-Aldrich/Supelco, Bellefonte, 
PA; 30 m × 0.25 mm ID × 0.25 m df). GC parameters were: initial 
pressure of carrier gas (helium) (constant linear velocity, 30 cm/s), 
99.5 kPa; temperature program, 120–260°C at 3°C/min; injection 
volume, 1 l; split ratio, 1:100. FID parameters were: temperature, 
265°C; H2 flow rate, 40 ml/min; air flow rate, 400 ml/min; make-
up gas (He) flow rate, 50 ml/min. Data acquisition was performed 
using the GCsolution software.
An aliquot of the PFC and hippocampus lipid extract for each 
sample was mildly saponified and fatty acids were analyzed by 
HPLC (Agilent 1100 HPLC system with diode array detector; Palo 
Alto, CA) as previously described (19). Spectra (195–315 nm) 
of the eluate were obtained every 1.28 s and were electronically 
stored. These spectra were acquired to confirm identification of 
the HPLC peaks (20).
Because saturated fatty acids are transparent to UV, after de-
rivatization, they were measured as FAMEs by a gas chromato-
graph (Agilent Model 6890) as described (21).
Diet administration
Diets were administered according to the timeline reported in 
Fig. 1A. Time-mated Sprague-Dawley rats were fed a diet containing 
6% fat in the form of peanut oil rich in LA (n-3-deficient diet), a diet 
containing 6% fat in the form of rapeseed oil rich in ALA (n-3-en-
riched diet), or a standard diet composed of 3% peanut oil and 3% 
rapeseed oil throughout gestation and lactation. Diets were isocalo-
ric and did not differ with respect to the n-6 content. After weaning, 
the offspring received the same diet throughout the rest of their life 
to model a lifetime of n-3 deficiency or supplementation.
Behavioral tests
Classic and spatial versions of the novel object recognition test. The 
experimental apparatus used for the object recognition test was an 
open-field box (43 × 43 × 32 cm) made of Plexiglas placed in a 
dimly illuminated room. The experiment was performed and ana-
lyzed as previously described (22). Animals performed each test 
individually. Briefly, each animal was placed in the arena and al-
lowed to explore two identical previously unseen objects for 5 min 
(familiarization phase). After an inter-trial interval of 3 min, one of 
the two familiar objects was replaced by a novel previously unseen 
object and rats were returned to the arena for the 5 min test phase. 










304 Journal of Lipid Research Volume 58, 2017
Autoradiographic-binding assays
Rats were euthanized and brains were rapidly removed, frozen 
in liquid nitrogen, and stored at 80°C until processing. Coronal 
sections (20 m thick) were cut on a cryostat and mounted on 
gelatin-coated slides. The sections were stored at 80°C until 
processing.
[3H]CP-55,940 receptor autoradiographic binding
The [3H]CP-55,940 receptor autoradiographic binding was 
performed as previously described (27, 28).
CP-55,940-stimulated [35S]GTPS binding in 
autoradiography
This was determined as previously described (27, 28).
Image analysis
The intensity of the autoradiographic films was assessed by 
measuring the gray levels with an image analysis system consisting 
of a scanner connected to a computer running Microsoft Windows. 
continued for the remainder of the session. Each session consisted 
of three consecutive sequences of trials. During the first and the 
third sequence, the rats were presented with five pulse-alone trials of 
115 dB. The second sequence consisted of 50 trials in pseudo-ran-
dom order, including 12 pulse-alone trials, 30 trials of pulse pre-
ceded by 73, 76, or 82 dB prepulses (10 for each level of prepulse 
loudness), and eight no stimulus trials, where only the background 
noise was delivered. Intertrial intervals were selected randomly be-
tween 10 and 15 s. Acoustic devices and startle cages were connected 
to a computer, which detected and analyzed all chamber variables 
using customized software. Percent PPI was calculated with the fol-
lowing formula: 100  [(mean startle amplitude for prepulse  
pulse trials/mean startle amplitude for pulse  alone trials) × 100].
Biochemical studies
The long-term effects of diet administration on components of 
the endocannabinoid system were evaluated in the adult male off-
spring (PND 75). Biochemical analyses were performed on ani-
mals that underwent novel object recognition (NOR), social 
interaction, and FSTs 24 h after the last test.
Fig. 1. A: Scheme of diet administration. Diets were administered to time-mated Sprague-Dawley rats through-
out gestation and lactation. After weaning, the offspring received the same diet throughout the rest of their life 
to model a lifetime of n-3 deficiency or supplementation. B: Body weight gain, food intake in dams during gesta-
tion, and the number of fetuses delivered per dam. Data represent mean ± SEM of eight animals per group.










Dietary ALA-induced changes in behavior and brain endocannabinoids 305
quantified against 17:0-EA and 2-22:6-G, respectively, the internal 
standards for which calibration curves had been constructed in 
pilot experiments. Lipid amounts expressed as picomoles were 
then normalized per gram or milligram of wet tissue.
Statistical analysis
Results are expressed as mean ± SEM and were analyzed by two- 
or one-way ANOVA, followed up by Bonferroni’s post hoc test. 
The level of statistical significance was set at P < 0.05.
RESULTS
Diet composition
Table 1 reports the fatty acid composition of the diets 
used in this study. The n-3-deficient diet contained 6% fat 
in the form of peanut oil rich in LA (n-3:n-6 ratio = 1:23,9), 
the n-3-enriched diet contained 6% fat in the form of rape-
seed oil rich in ALA (n-3:n-6 ratio = 1:4,5), and the stan-
dard diet was composed of 3% peanut oil and 3% rapeseed 
oil (n-3:n-6 ratio = 1:8,6).
Effect of lifelong dietary n-3 enrichment or deficiency on 
fatty acid contents in the PFC and hippocampus
To assess whether altered dietary ALA/LA ratio could ac-
tually affect brain fatty acid profile in the offspring, we 
quantified the fatty acid contents in the PFC and hippocam-
pus of adult male rats after lifelong diet administration. The 
results are shown in Tables 2, 3. In the PFC (Table 2), con-
sumption of n-3-enriched diets significantly decreased 18:2 
n-6 and 20:3 n-6 contents by about 20% and 21% with re-
spect to animals fed a standard diet. Administration of n-
3-deficient diets significantly reduced 22:5 n-3 and 18:2 n-6 
levels by about 32% and 35% compared with rats fed a stan-
dard diet. Lifelong dietary n-3 deficiency also significantly 
increased 20:3 n-6, 22:4 n-6, and 22:5 n-6 contents by about 
60%, 10%, and 142%, respectively. Both dietary regimens 
did not affect DHA 22:6 n-3 and ARA 20:4 n-6 levels in this 
brain region. In the hippocampus (Table 3), n-3-enriched 
diets significantly increased 22:5 n-3 and 22:4 n-6 levels by 
about 29% and 15% compared with the standard diet. Sig-
nificant decreases in DHA 22:6 n-3 (8%) and 22:5 n-6 
(33%) levels were also present. Administration of n-3-defi-
cient diets resulted in significant reductions by about 27% 
and 12% of 22:5 n-3 and DHA 22:6 n-3 contents, and in 
significant increases by about 9% and 108% of 22:4 n-6 and 
22:5 n-6 levels. Neither enriched nor deficient diets altered 
hippocampal 18:2 n-6, 20:3 n-6, and ARA 20:4 n-6 levels.
The images were analyzed using Image-Pro Plus 7.0 (Media Cy-
bernetics, Silver Spring, MD) as previously described (29).
Western blot analyses
For Western blot analyses, rats were euthanized and brains 
quickly removed. The cerebral areas of interest (PFC, hippocam-
pus, and amygdala) were obtained by regional dissection on ice, 
immediately frozen in liquid nitrogen, and stored at 80°C until 
processing.
The experiments were carried out as previously reported (30). 
Briefly, equal amounts of protein lysates (30 g) were run on a 
10% SDS-polyacrylamide gel. The proteins were then transferred 
to polyvinylidene difluoride membranes, blocked for 2 h at room 
temperature in 5% dry skimmed milk in TBS1x 0.1% Tween-20 
before incubation overnight at 4°C with the primary antibody. 
The following primary antibodies were used: rabbit polyclonal 
anti-CB1 (1:1,000; Cayman Chemical, Ann Arbor, MI), rabbit poly-
clonal anti-NAPE-PLD (1:3,000; Cayman Chemical), rabbit poly-
clonal anti-FAAH (1:2,000; Cayman Chemical), goat polyclonal 
anti-DAGL (1:1,000; Abcam, Cambridge, UK), rabbit polyclonal 
anti-MAGL (1:1,000; Cayman Chemical). Bound antibodies were 
detected with HRP-conjugated secondary anti-rabbit or anti-goat 
antibody (1:2,000 to 1:5,000; Chemicon International, Temecula, 
CA). For normalization, the blots were stripped with Restore 
Western blot stripping buffer (Thermo Scientific, Rockford, IL) 
and reblotted with mouse anti--actin monoclonal antibody 
(1:10,000; Sigma-Aldrich, Italy) overnight at 4°C. Bound antibod-
ies were visualized using Clarity Western ECL substrate (Bio-Rad 
Laboratories, Hercules, CA) and bands were detected with a 
GBOX XT camera (Syngene, Cambridge, UK). Optical density of 
the bands was quantified using Image Pro Plus 7.0 software (Me-
dia Cybernetics, Bethesda, MD). The density of the bands was nor-
malized to -actin and expressed as arbitrary units.
Lipid extraction and endocannabinoid measurement
PFC, hippocampus, and amygdala were dounce-homogenized 
and extracted with chloroform/methanol/Tris-HCl (50 mM, pH 
7.4) (2:1:1, v/v) containing internal deuterated standards for 
AEA, PEA, OEA, docosahexaenoyl ethanolamide (DHA-EA), and 
2-AG, quantification by isotope dilution [8-AEA, d4-PEA, d4-OEA, 
d4-DHA-EA, and d5-2-AG, (Cayman Chemical)], as well as 17:0-
AE (Cayman Chemical) and 2-17:0-G (Larodan AB, Malmo, Swe-
den) for 18:2-EA, eicosapentaenoyl ethanolamide (EPA-EA), and 
2-22:6-G measurement, respectively.
The lipid-containing organic phases were then purified by open 
bed chromatography on silica and fractions were obtained by elut-
ing the column with 99:1, 90:10, and 50:50 (v/v) chloroform/meth-
anol. Fractions eluted with chloroform/methanol 90:10 were 
collected, the excess solvent evaporated with a rotating evaporator, 
and aliquots analyzed by isotope dilution-LC/atmospheric pressure 
chemical ionization/MS carried out in the selected ion monitoring 
mode by using a Shimadzu HPLC apparatus (LC-10ADVP) coupled 
to a Shimadzu (LCMS-2020) quadrupole mass spectrometer via a 
Shimadzu atmospheric pressure chemical ionization interface.
MS detection was performed by using values of m/z 356 and 348 
(molecular ions + 1 for d8-AEA and AEA), m/z 304 and 300 (mo-
lecular ions + 1 for d4-PEA and PEA), m/z 330 and 326 (molecular 
ions + 1 for d4-OEA and OEA), m/z 376 and 372 (molecular ions 
+ 1 for d4-DHA-EA and DHA-EA), m/z 384 and 379 (molecular 
ions +1 for d5-2-AG and 2-AG), m/z 346 (molecular ions + 1 for 
EPA-EA), m/z 324 (molecular ions + 1 for 18:2-EA), m/z 314 (mo-
lecular ions + 1 for 17:0-EA), m/z 403 (molecular ions + 1 for 
2-22:6-G), and m/z 345 (molecular ions + 1 for 2-17:0-G).
AEA, PEA, OEA, DHA-EA, and 2-AG levels were therefore cal-
culated on the basis of their area ratios with the internal deuter-
ated standard signal areas. EPA-EA, 18:2-EA, and 2-22:6-G were 
TABLE 1. Fatty acid composition of the dietary lipids (relative 
percent of total fatty acids)
Standard Diet n-3-Enriched Diet n-3-Deficient Diet
LA 32.0 27.5 33.3
ALA 3.7 6.0 1.4
Monounsaturated fats 35.7 48.3 38.7
Polyunsaturated fats 35.7 33.6 34.7
n-3:n-6 ratio 1:8.6 1:4.5 1:23.9
Energy content (kcal/g) 4.09 4.05 4.12
All diets were isocaloric, had the same amount of n-6, and differ 
only for n-3 content.
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was also observed in the spatial version of the test, the dis-
crimination index being reduced by about 64% and 50% 
in both experimental groups.
In contrast, diet administration did not significantly af-
fect emotional memory in the inhibitory avoidance task, as 
demonstrated by the presence of similar retention perfor-
mances in all the experimental groups.
Figure 3 reports the effects of diet administration on 
measures of depressive- and anxiety-like behaviors, such as 
the social interaction test (Fig. 3A), the FST (Fig. 3B), and 
the elevated plus maze (Fig. 3C), as well as on psychotic-
like symptoms, through the PPI test (Fig. 3D).
Statistical analysis revealed a significant effect of diets in 
the social interaction test (F2,17 = 6.628; P = 0.0062) and 
FST (immobility: F2,17 = 4.468, P = 0.0257; climbing: F2,17 = 
7.512, P = 0.0039). Administration of n-3-enriched diets 
induced a significant reduction in the time spent in active 
social behaviors in the 10 min test session by about 52% 
when compared with controls. Similarly, in the FST, rats 
fed n-3-enriched diet displayed a significant increase by 
about 60% in the time spent in immobility during the 
15 min test session, paralleled by a significant 36% reduc-
tion of the time spent in climbing activity. In contrast, 
n-3-deficient diet administration did not alter the animals’ 
behavior in the social interaction test and FST.
Conversely, no significant effects were instead observed 
in the elevated plus maze test, because administration of 
n-3-deficient and -enriched diets did not change the time 
spent in the open arms and the percentage of open arm 
entries with respect to controls. This effect did not appear 
to be due to motoric effects, as there was no change in total 
arm entries (data not shown).
Finally, dietary fatty acid composition had no effect on 
PPI responses in the adult offspring.
Behavioral consequences of n-3 enrichment or deficiency 
restricted to gestation and lactation
In order to dissect between the behavioral effect of life-
long or perinatal administration of n-3-deficient or -enriched 
diets, we performed a separate experiment in which diets 
were given either lifelong or during gestation and lactation 
only. The offspring belonging to all experimental groups 
were then tested for behavior at adulthood, i.e., PND 75.
Figure 4 represents the effects of lifelong or perinatal 
diet administration on recognition memory (Fig. 4B) and 
depressive-like behaviors, as measured through the social 
interaction test (Fig. 4C) and FST (Fig. 4D).
Statistical analysis revealed the main effects of diet, time, 
and diet × time interaction in the NOR test (diet: F2,30 = 
48.61, P < 0.0001; time: F1,30 = 12.92, P = 0.0011; diet × time 
interaction: F2,30 = 11.54, P = 0.0002). As expected, lifelong 
administration of both n-3-deficient or -enriched diets sig-
nificantly reduced the discrimination index in the adult 
offspring by about 70% with respect to animals fed a stan-
dard diet. Interestingly, n-3 deprivation during gestation 
and lactation was sufficient to induce a significant impair-
ment of recognition memory in adult animals. In contrast, 
administration of n-3-enriched diet restricted to gestation and 
lactation did not alter recognition memory at adulthood.
TABLE 2. Effect of lifelong administration of n-3-enriched or 
-deficient diets on the fatty acid profile in the PFC of adult rats
Standard Diet n-3-Enriched Diet n-3-Deficient Diet
22:5 n-3 0.752 ± 0.024 0.508 ± 0.040b 0.883 ± 0.053
DHA 22:6 n-3 12.745 ± 0.167 11.595 ± 0.480 13.571 ± 0.288
18:2 n-6 2.319 ± 0.136 1.496 ± 0.039a 1.845 ± 0.042c
20:3 n-6 0.418 ± 0.017 0.667 ± 0.008a 0.328 ± 0.016b
ARA 20:4 n-6 12.041 ± 0.259 12.080 ± 0.344 12.343 ± 0.081
22:4 n-6 2.197 ± 0.048 2.427 ± 0.068b 2.303 ± 0.022
22:5 n-6 0.617 ± 0.016 1.492 ± 0.141a 0.422 ± 0.010
Data represent mean ± SEM for four rats per group and are 
expressed as nanomoles per milligram of lipid.
aP < 0.001 versus standard diet.
bP < 0.01 versus standard diet.
cP < 0.05 versus standard diet.
TABLE 3. Effect of lifelong administration of n-3-enriched  
or -deficient diets on the fatty acid profile in the hippocampus of  
adult rats
Standard Diet n-3-Enriched Diet n-3-Deficient Diet
22:5 n-3 0.248 ± 0.014 0.180 ± 0.009c 0.319 ± 0.044c
DHA 22:6 n-3 11.394 ± 0.043 10.048 ± 0.199a 10.423 ± 0.164b
18:2 n-6 1.444 ± 0.136 1.302 ± 0.095 1.651 ± 0.082
20:3 n-6 0.522 ± 0.033 0.631 ± 0.031 0.442 ± 0.019
ARA 20:4 n-6 12.665 ± 0.232 12.733 ± 0.316 12.218 ± 0.353
22:4 n-6 2.284 ± 0.045 2.491 ± 0.044c 2.641 ± 0.089b
22:5 n-6 0.579 ± 0.028 1.202 ± 0.041a 0.385 ± 0.023b
Data represent mean ± SEM for four rats per group and are 
expressed as nanomoles per milligram of lipid.
aP < 0.001 versus standard diet.
bP < 0.01 versus standard diet.
cP < 0.05 versus standard diet.
Effect of diet administration on body weight, food intake, 
and pregnancy outcome in time-mated Sprague-Dawley 
rats
As shown in Fig. 1B, administration of n-3-deficient and - 
enriched diets during gestation did not affect body weight 
gain and food intake in time-mated rats when compared 
with controls fed a standard chow diet. Furthermore, the 
number of fetuses delivered per dam was similar for all the 
diets considered and no changes in body weight gain were 
observed in the offspring (data not shown).
Behavioral consequences of lifelong dietary n-3 
imbalances in the male offspring
Male adult (PND 75) offspring were submitted to a series 
of behavioral tests to evaluate the long-term consequences 
of dietary n-3 imbalances from pregnancy on cognitive per-
formance, emotional reactivity, and psychotic-like symptoms.
Figure 2 shows the consequences of diet administration 
on recognition and emotional memory, as measured 
through the NOR test (Fig. 2A) and the inhibitory avoid-
ance task (Fig. 2B), respectively.
One-way ANOVA showed significant effects of diet ad-
ministration both in the classic (F2,17 = 9.392; P = 0.0035) 
and in the spatial (F2,17 = 5.892; P = 0.0121) versions of the 
NOR test. Lifelong administration of both n-3-deficient 
and -enriched diets resulted in impaired cognitive perfor-
mance in the classic version of the NOR test in the adult 
male offspring, as stated by the significant reductions of the 
discrimination index by about 76% and 60%, respectively, 
compared with controls fed a standard diet. A similar effect 
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Diet-induced changes in the endocannabinoid system 
in the PFC, hippocampus, and amygdala of adult male 
offspring
Biochemical analyses were carried out in the brains of 
the adult offspring in order to determine whether lifelong 
dietary n-3 deficiency or supplementation could impact 
the endocannabinoid system in the long-term. Specifically, 
CB1 receptor density and functionality and protein expres-
sion of endocannabinoid synthetic and degradative en-
zymes (NAPE-PLD, DAGL, FAAH, and MAGL), as well as 
the levels of n-3- and n-6-derived endocannabinoids, were 
monitored in the PFC, hippocampus, and amygdala, brain 
regions closely involved in the modulation of cognition 
and emotionality.
Figure 5 reports the effect of diet administration on the 
endocannabinoid system in the PFC of adult male rats.
The composition of dietary fatty acids did not alter CB1 
receptor expression and G protein coupling within this 
brain area (Fig. 5A). In contrast, statistical analysis revealed 
that both n-3 deficiency and supplementation significantly 
affected the expression of the degradative enzymes for en-
docannabinoids, FAAH (F2,14 = 7.450; P = 0.0241) and 
MAGL (F2,14 = 11.10; P = 0.0037). The n-3 supplementation 
significantly increased the expression of both FAAH and 
MAGL by about 50% and 180%, respectively, when compared 
with control rats. Similarly, administration of an n-3-deficient 
Fig. 2. Effect of diet administration on nonemotional and emotional memories in the adult male offspring. 
A: Cognitive performance in the NOR test in the classic (left panel) and in the spatial (right panel) versions 
of the task. The discrimination index was calculated as follows: [(En  Ef)/(En + Ef)] × 100. B: Inhibitory 
avoidance retention latencies in seconds. Rats were given foot shock in compartment A and 48 h later they 
were tested for retention latencies in the same apparatus. Data represent mean ± SEM of eight animals per 
group for the NOR test and mean ± SEM of 10 to 11 animals per group for the inhibitory avoidance task.  
*P < 0.05 versus standard diet (Bonferroni’s post hoc test).
In the social interaction test, two-way ANOVA showed 
significant main effects of diet, time, and diet × time inter-
action (diet: F2,30 = 3.738, P = 0.0355; time: F1,30 = 12.01, P = 
0.0016; diet × time interaction: F2,30 = 20.96, P < 0.0001). 
Lifelong administration of n-3-enriched diets induced a 
significant reduction in the time spent in active social 
behaviors by about 50% when compared with controls; 
whereas, lifelong administration of n-3-deficient diet did 
not alter sociability in the long-term. Interestingly, n-3-en-
riched diets given during gestation and lactation only did 
not alter social behaviors in the adult offspring. A similar 
effect was also observed in the FST. Indeed, statistical analy-
sis revealed the main effects of diet, time, and diet × time 
interaction in the time spent in immobility (diet: F2,30 = 
8.016, P = 0.0016; time: F1,30 = 11.46, P = 0.0020; diet × time 
interaction: F2,30 = 17.54, P < 0.0001) and climbing activities 
(diet: F2,30 = 11.33, P = 0.0002; time: F1,30 = 9.502, P = 0.0044; 
diet × time interaction: F2,30 = 12.73, P < 0.0001). Lifelong 
administration of n-3-enriched diets led to a significant in-
crease, by about 50%, in the time spent in immobility, par-
alleled by a significant 35% reduction of the time spent in 
climbing activity, in the adult offspring. In contrast, no 
alterations were observed in adult animals that were fed 
n-3-enriched diets only during perinatal life. Finally, nei-
ther lifelong nor perinatal administration of n-3-deficient 
diets altered the animals’ behavior in the FSTs.
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Fig. 3. Effect of diet administration on depressive- and anxiety-like behaviors and psychotic-like signs in the adult male offspring. A: Active 
social behaviors in the social interaction test. B: Time spent in immobility, climbing, and swimming in the FST. C: Time spent in the open 
arms and open arm entries in the elevated plus maze test. D: PPI response. Data represent mean ± SEM of eight animals per group for the 
social interaction and FSTs and mean ± SEM of 10 to 11 animals per group for the elevated plus maze and PPI tasks. *P < 0.05 versus standard 
diet (Bonferroni’s post hoc test).
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dietary n-3 intake triggered significant changes in the levels 
of AEA (F2,9 = 5.824; P = 0.0238) and 2-AG (F2,9 = 5.377; P = 
0.0291), as well as the n-3 derivative, MAG 2-22:6 (F2,9 = 
8.389; P = 0.0151). Levels of AEA and 2-AG significantly 
decreased by about 70% and 40% in the PFC after adminis-
tration of n-3-enriched diets. A significant 50% reduction of 
MAG 2-22:6 was also observed in this experimental group. 
diet resulted in a significant 200% increase in MAGL ex-
pression without altering FAAH protein levels. No altera-
tions on NAPE-PLD and DAGL expression were observed 
in any of the experimental groups considered (Fig. 5B). 
Changes in degradative enzymes were paralleled by signifi-
cant alterations of endocannabinoid levels within the PFC 
(Fig. 6). One-way ANOVA showed that modifications of 
Fig. 4. Long-term consequences of lifelong or perinatal administration of n-3-deficient or -enriched diets. 
Experimental procedure (A), recognition memory (B), and depressive-like behaviors (C and D) as measured 
through the social interaction test and forced swim test. Data represent mean ± SEM of six animals per group. 
**P < 0.01; *P < 0.05 versus standard diet; °°P < 0.01, °P < 0.05 versus lifelong administration of n-3-enriched 
diet (Bonferroni’s post hoc test).
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Fig. 5. Effect of dietary n-3 intake on the endocannabinoid system within the PFC of adult male offspring. 
A: [3H]CP-55,940 receptor binding in autoradiography (left panel) and CP-55,940-stimulated [35S]GTPS 
binding in autoradiography (right panel). Results are expressed as mean ± SEM of four animals per group. B: 
Protein levels of synthetic and degradative enzymes for endocannabinoids. Data are expressed as arbitrary 
units and represent mean ± SEM of five animals per group. *P < 0.05 versus standard diet (Bonferroni’s post 
hoc test). C: Representative Western blot images of FAAH and MAGL. -Actin was probed as loading control.
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In contrast, administration of n-3-deficient diets led to re-
ductions of 2-AG (30%) and MAG 2-22:6 (40%), with-
out affecting AEA levels. PEA, OEA, DHA-EA, EPA-EA, and 
18:2-EA levels were not altered by the different dietary 
conditions.
Alterations of the endocannabinoid system were also 
present in the hippocampus of adult male rats after admin-
istration of both n-3-deficient and -enriched diets (Figs. 7, 8). 
Administration of both n-3-deficient and -enriched diets 
significantly reduced CB1 receptor functionality by about 
30% within the hippocampus of the adult male offspring 
(F2,9 = 4.452; P = 0.0194), whereas no effect was observed 
on CB1 receptor density (Fig. 7A). Diet administration also 
affected the expression of the enzymes responsible for en-
docannabinoid synthesis and degradation (Fig. 7B). Spe-
cifically, statistical analysis showed an effect of dietary n-3 
intake on NAPE-PLD (F2,14 = 5.746; P = 0.0247) and MAGL 
(F2,14 = 7.911; P = 0.0127) expression. Lifelong administra-
tion of n-3-enriched diets significantly reduced NAPE-PLD 
protein levels by about 40% and increased MAGL expres-
sion by about 60% when compared with controls fed a stan-
dard diet. No alterations were observed after administration 
of n-3 deficient diets.
As shown in Fig. 8, diet administration also affected 
endocannabinoid levels within the hippocampus (AEA: 
F2,9 = 5.245, P = 0.0277; 2-AG: F2,9 = 4.467, P = 0.0449; MAG 
2-22:6: F2,9 = 8.114, P = 0.0097; DHA-EA: F2,9 = 11.55, P = 
0.0033). Levels of AEA and 2-AG decreased in this brain 
region after administration of n-3-enriched diet. A similar 
decrease was also observed for MAG 2-22:6, its levels being 
reduced by about 60% after administration of the en-
riched diet. In contrast, n-3 enrichment resulted in a sig-
nificant increase, by about 60%, of the levels of the n-3 
derivative, DHA-EA. No significant changes were observed 
in animals that underwent administration of n-3-deficient 
diets and dietary n-3 content did not affect PEA, OEA, 
EPA-EA, and 18:2-EA levels.
Finally, in the amygdala, dietary fatty acid composition 
did not affect CB1 receptor density and functionality or 
AEA, 2-AG, PEA, OEA levels within this brain region (data 
not shown).
DISCUSSION
The present results indicate that sustained imbalances in 
dietary ALA from pregnancy have long-term consequences 
on adult offspring behavior in terms of cognitive and 
emotional functions. Specifically, we found that lifelong 
administration of both ALA-deficient and -enriched diets 
Fig. 6. Tissue concentrations of n-6-derived endocannabinoids (AEA, 2-AG, PEA, OEA) and n-3-derivatives (DHA-EA, EPA-EA, 18:2-EA, 
MAG 2-22:6) in the PFC of adult male rats after lifelong administration of deficient and enriched diets. Data are expressed as the mean ± 
SEM of four animals per group. *P < 0.05; **P < 0.01 versus standard diet (Bonferroni’s post hoc test).
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Fig. 7. Effect of dietary n-3 intake on the endocannabinoid system within the hippocampus of adult male 
offspring. A: [3H]CP-55,940 receptor binding in autoradiography (left panel) and CP-55,940-stimulated [35S]
GTPS binding in autoradiography (right panel). Results are expressed as mean ± SEM of four animals per 
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The n-3 and n-6 LCPUFAs are essential elements in the 
assembly, maturation, and physiological function of neuro-
nal structures, and optimal neuronal development is highly 
dependent on the supply of LCPUFAs (2). Thus, dysregula-
tion in brain n-3 LCPUFA content could adversely affect 
brain maturation and neuronal activity, and a diet balanced 
in n-6 and n-3 contents should be recommended to ensure 
normal brain functions. Accordingly, our data demonstrate 
that when the optimal n-6/n-3 ratio is lost, both following 
dietary ALA deficiency and enrichment, long-term behav-
ioral abnormalities in cognition and emotionality arise.
However, literature data on the effects of dietary n-3 
deficiency and supplementation are often conflicting. 
Impairment in several aspects of learning and memory 
has been reported as a consequence of pre- and postnatal 
dietary n-3 deficiency (32–35), while a transient or mater-
nal n-3 PUFA-deficient diet has been reported to induce 
depressive- and anxiety-like symptoms, as well as abnormal 
social behavior in adult offspring (17, 18, 36–40). Notably, 
other studies found opposite or no effects of different 
n-3-deficient and -supplemented diets on behavior (41–
46). Interestingly, the discriminant is DHA concentration. 
induced lasting short-term memory deficits in the NOR test; 
whereas, dietary ALA enrichment also resulted in abnor-
mal emotional reactivity in the social interaction test and 
FST in adult male rats with respect to animals fed a stan-
dard diet, balanced in n-3 content. Accordingly, we found 
a decrease of DHA in the PFC of rats fed both ALA-defi-
cient and -enriched diets with respect to control diet. The 
decrease of DHA in the brains of rats fed an ALA-deficient 
diet has already been described in mice (17, 18). However, 
the decrease of DHA in the brains of rats fed the ALA-en-
riched diet is also not surprising, because it has been shown 
that high dietary ALA inhibits delta 6 desaturase, impairing 
the formation of the direct precursor of DHA, c24:6n-3 
fatty acid (31). In fact, we found an increase of the other 
precursor, 22:5n-3. Interestingly, in our experimental con-
ditions, we didn’t detect any change in AA content in con-
trast with previous findings in mice (17, 18). Thus, we may 
suggest that long-term feeding of imbalanced n-3/n-6 ratio 
diets from the gestational period may result in a physiologi-
cal response to maintain a steady AA concentration in the 
brain by modulating its metabolism, including endocan-
nabinoid biosynthetic and degrading enzymes.
group. B: Protein levels of synthetic and degradative enzymes for endocannabinoids. Data are expressed as 
arbitrary units and represent mean ± SEM of five animals per group. *P < 0.05 versus standard diet (Bonfer-
roni’s post hoc test). C: Representative Western blot images of NAPE-PLD and MAGL. -Actin was probed as 
loading control.
Fig. 8. Tissue concentrations of n-6-derived endocannabinoids (AEA, 2-AG, PEA, OEA) and n-3-derivatives (DHA-EA, EPA-EA, 18:2-EA, 
MAG 2-22:6) in the hippocampus of adult male rats after lifelong administration of deficient and enriched diets. Data are expressed as the 
mean ± SEM of four animals per group. *P < 0.05 versus standard diet (Bonferroni’s post hoc test).
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Endocannabinoids include the fatty acid ethanolamides, 
AEA, OEA, and PEA, as well as the ester, 2-AG, biosynthe-
sized from PUFAs of the n-6 family, and those biosyn-
thesized from n-3 PUFAs, such as EPA-EA and DHA-EA 
(48–50). Endocannabinoids are important regulators of 
synaptic function (16). They suppress neurotransmitter re-
lease by acting as retrograde messengers at presynaptic CB1 
receptors. Retrograde endocannabinoid signaling medi-
ates short-term forms of synaptic plasticity, as well as pre-
synaptic forms of long-term depression at both excitatory 
and inhibitory synapses (51). Moreover, the endocannabi-
noid system has been shown to play a central role in the 
modulation of mood and cognition both at adulthood and 
during critical developmental stages (52), and it is engaged 
in food addiction (53).
In the present paper, we demonstrated that dietary ALA 
profoundly alters the brain endocannabinoid system, in 
terms of both endocannabinoid levels as well as their syn-
thetic and degrading enzymes. Both ALA deficiency and 
enrichment increase MAGL levels in the PFC and hippo-
campus with respect to rats fed the standard diet and this is 
associated with reductions of 2-AG and MAG 2-22:6 levels. 
In the same brain regions, lifelong administration of ALA-
enriched diets also reduces AEA levels, possibly via in-
creased AEA degradation by FAAH in the PFC and reduced 
AEA synthesis by NAPE-PLD in the hippocampus. Intrigu-
ingly, ALA-deficient and -enriched diets alter AEA and 
2-AG contents without affecting the concentrations of “en-
tourage compounds”, such as PEA and OEA. The obser-
vation that whenever MAGL expression is increased, 
reductions of both 2-AG and MAG 2-22:6 are found, 
strongly suggests that MAGL could also be responsible for 
the degradation of this n-3-derived endocannabinoid. As 
mentioned above, the modulation of biosynthetic and de-
grading enzymes of AEA and 2-AG, as well of MAG 2-22:6, 
might be envisaged as a physiological mechanism to main-
tain brain AA and DHA steady concentrations.
As recent evidence indicates that MAGL deletion and 
subsequent elevation of 2-AG levels enhance memory in 
the NOR test (54), it is tempting to speculate that the cog-
nitive impairments induced by both ALA-deficient and -en-
riched diets, other than DHA decrease, could possibly be a 
consequence of deficient 2-AG signaling within the PFC 
and hippocampus. Conversely, reduced AEA levels, as well 
as FAAH dysfunction, have been linked to depression both 
in animals and humans (55–58), consistent with the phe-
notype observed in rats administered with ALA-enriched 
diets. Of course, these hypotheses are merely speculative at 
this time, and further studies are needed to clearly estab-
lish any specific correlation. Of note, the expression of en-
docannabinoid system components can be regulated by 
epigenetic mechanisms (59), and food intake has, indeed, 
been shown to modulate CB1 expression via DNA methyla-
tion (47). Therefore, it is tempting to speculate that the 
modulation of endocannabinoid system protein expression 
by ALA shown here occurs through epigenetic mechanisms.
Finally, both diets did not alter the animals’ performance 
in the inhibitory avoidance task and, accordingly, no 
changes in CB1 receptor and endocannabinoid content 
In fact, it is well-established that dietary ALA deficiency re-
sults in DHA brain deficiency; whereas, the most efficient 
strategy to increase DHA levels in brain is its dietary in-
take, more efficiently in the phospholipid form, as in 
Krill oil (21). In our hands, lifelong administration of n-
3-deficient diets impaired short-term memory performance 
in adult offspring when compared with controls fed a stan-
dard diet without inducing any depressive- or anxiety-like 
symptom.
Discrepancies in the literature data could be attributed 
to differences in diet compositions, such as the type of n-3 
fatty acid and protocols of administration used. Indeed, to 
reach an imbalanced n-6/n-3 ratio in the n-3-deficient di-
ets, in some studies overall n-6 content was markedly in-
creased (17, 18, 39, 45), while in others n-3 fatty acids were 
completed depleted (37, 40). Moreover, great variability in 
the time window and duration of administration was also 
present. Diets were administered either starting before 
mating (42, 46), during gestation and lactation (37, 43, 
45), after weaning (38), from pregnancy throughout adult-
hood (17, 18, 44), or across consecutive generations (41). 
Our findings further highlight the importance of the time 
window of administration in determining the detrimental 
behavioral effects of dietary ALA enrichment or deficiency. 
In fact, when isocaloric diets enriched or deficient in ALA, 
but with similar overall LA, were administered from preg-
nancy throughout adulthood, both dietary regimens led to 
significant behavioral abnormalities in the adult male off-
spring. In contrast, when ALA enrichment or deficiency 
was restricted to gestation and lactation, a different picture 
was observed. In fact, while administration of n-3-deficient 
diets restricted to this period was sufficient to impair recog-
nition memory in adult animals, no behavioral alterations 
in terms of either cognitive deficits or depressive-like behav-
iors were observed in the adult offspring after administration 
of n-3-enriched diets. Thus, it appears that the perinatal 
phases are the more sensitive period for the negative con-
sequences of n-3 deficiency on cognition; whereas, the 
adverse effects of n-3 enrichment arise only when en-
riched diets are administered for a longer period (i.e., 
lifelong).
Among others, one of the added values of our study is 
that it also investigated the effects of lifelong ALA enrich-
ment per se in comparison to a standard diet. This finding 
further underlines the importance of the right PUFA com-
position for proper brain development and behavior. 
Thus, clinical studies investigating the efficacy of n-3 PU-
FAs for the treatment of neurological conditions should 
take into account the initial n-3 LCPUFA status of the sub-
jects in order to determine the optimal dose required to 
achieve any potential benefit. Indeed, n-3 LCPUFA supple-
mentation could exert some benefits by restoring a bal-
anced n-6/n-3 ratio in those subjects in which n-3 intake is 
deficient.
In the context of the possible molecular mechanisms in-
volved in the observed behavioral alterations, the endocan-
nabinoid system could represent an ideal candidate to 
mediate the effects of dietary fatty acids on brain and be-
havior (47).
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were observed in the amygdala, a key area involved in the 
modulation of this behavioral response.
Endocannabinoids, both n-6 and n-3 derived, can bind 
and activate CB1 receptors, although with different affinity 
(60, 61). Both ALA-deficient and -enriched diets reduce 
CB1 receptor/G protein coupling in the hippocampus, 
whereas no changes were present in the PFC and amyg-
dala. Accordingly, it has recently been shown that lifelong 
administration of diets rich in ALA and LA reduced 
ERK1/2 phosphorylation in the hippocampus after treat-
ment with WIN55212-2 (18), suggesting an impairment in 
the CB1 signaling pathway after administration of both 
ALA-enriched and -deficient diets. In our hands, both ALA-
enriched and -deficient diets resulted in CB1 receptor de-
sensitization in the presence of decreased or unchanged 
2-AG and AEA contents in the hippocampus. Given that 
membrane lipid composition has been demonstrated to af-
fect CB1 cannabinoid receptor binding and signaling (62), 
it is possible that the effect of diets on CB1 receptor func-
tionality could be the consequence of alterations of brain 
fatty acid composition triggered by dietary PUFAs.
Taken together, these findings support the critical role 
of n-3 PUFAs in brain maturation and functioning by com-
paring the effects of diets enriched or deficient in ALA to 
those of a standard diet, thus highlighting the importance 
of a balanced diet that ensures adequate intake of key nu-
trients for mental health. More interestingly, our data 
support a link between dietary intake of ALA, brain endo-
cannabinoid system, and behavior, indicating that dietary 
ALA is a sufficient condition for altering the endocannabi-
noid system in brain regions modulating mood and cogni-
tion. Dietary n-3 PUFAs act as homeostatic regulators of 
the endocannabinoid system and adequate levels of di-
etary n-3 fatty acids are required for proper endocannabi-
noid signaling. Overall, modulation of the endocannabinoid 
system by dietary n-3 PUFAs could represent an interest-
ing approach for future clinical investigations. However, 
attention should be paid when prescribing n-3 PUFA 
supplementation without specifying the type of n-3 PUFA 
as adjuvant treatment for psychiatric conditions, as its ef-
fect in terms of the CB1 receptor and/or endocannabi-
noids can be difficult to predict, especially after chronic 
intakes.
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